PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1385
https://www.valueinhealthjournal.com/article/S1098-3015(12)03098-7/fulltext
Title : PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03098-7&doi=10.1016/j.jval.2012.08.1385
First page : A444
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 883
Categories :
Tags :
Regions :
ViH Article Tags :